Association between serum insulin-like growth factor I or IGF-binding protein 3 and estimated glomerular filtration rate: results of a population-based sample

BMC Nephrology

Nele Friedrich⁵  Matthias Nauck⁵  Henry Völzke³  Karlhans Endlich¹  Sylvia Stracke²  Rainer Rettig⁴  Henri Wallaschofski⁵  Kathleen Dittmann⁵ 

[1] Institute of Anatomy and Cell Biology, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany;Department of Internal Medicine A, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany;Institute for Community Medicine, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany;Institute of Physiology, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany;Institute of Clinical Chemistry and Laboratory Medicine, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany

关键词: Study of health in Pomerania;    Renal function;    IGFBP-3;    IGF-I;    Insulin-like growth factor;    eGFR;   

Others  :  1083043
DOI  :  10.1186/1471-2369-13-169

 received in 2012-04-19, accepted in 2012-12-07,  发布年份 2012

【 摘 要 】

Background

Insulin-like growth factor I (IGF-I), which is mostly carried in blood by IGF-binding protein 3 (IGFBP-3), was associated to the glomerular filtration rate and chronic kidney disease in a multiethnic study among US adults. The aim of the present study was to investigate whether serum IGF-I or IGFBP-3 are associated with estimated glomerular filtration rate (eGFR) in a population-based study of Caucasian adults.

Methods

Data from 4028 subjects (2048 women) aged 20 to 81 years from the Study of Health in Pomerania (SHIP) were analyzed. Total serum IGF-I and IGFBP-3 concentrations were determined by chemiluminescence immunoassays and categorized into sex- and age-specific quartiles.

Results

After adjusting for age, waist circumference and type 2 diabetes mellitus, analysis of variance (ANOVA) revealed inverse associations between serum IGF-I concentrations and eGFR in men as well as between serum IGFBP-3 concentrations and eGFR in men and women. Logistic regression analyses confirmed these findings and showed that high IGF-I or IGFBP-3 concentrations were associated with an increased risk of decreased eGFR (<60 mL/min/1.73 m²) in men or women. These relations became stronger when lower eGFR cut-offs were used for the analyses.

Conclusion

Our data revealed associations of increased serum IGF-I concentrations and decreased eGFR in men but not in women and an association of increased serum IGFBP-3 concentrations and decreased eGFR in both sexes.

【 授权许可】

   
2012 Dittmann et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Juul A: Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003, 13:113-170.
• [2]Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16:3-34.
• [3]Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H: Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int 1999, 56:2076-2084.
• [4]Perticone F, Maio R, Sciacqua A, Perticone M, Laino I, Miceli S, Mazzaferro D, Pascale A, Andreozzi F, Giorgio S: Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients. J Hypertens 2009, 27:613-617.
• [5]Colao A, Di Somma C, Cascella T, Pivonello R, Vitale G, Grasso LF, Lombardi G, Savastano S: Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol 2008, 159:389-397.
• [6]Kalantar-Zadeh K, Unruh M: Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol 2005, 37:367-378.
• [7]Perovic S, Jankovic S: Renal transplantation vs hemodialysis: cost-effectiveness analysis. Vojnosanit Pregl 2009, 66:639-644.
• [8]Lepenies J, Wu Z, Stewart PM, Strasburger CJ, Quinkler M: IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease. Growth Horm IGF Res 2010, 20:93-100.
• [9]Atamer A, Alisir Ecder S, Akkus Z, Kocyigit Y, Atamer Y, Ilhan N, Ecder T: Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease. J Int Med Res 2008, 36:522-528.
• [10]Teppala S, Shankar A, Sabanayagam C: Association between IGF-1 and chronic kidney disease among US adults. Clin Exp Nephrol 2010, 14:440-444.
• [11]Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, et al.: Cohort profile: the study of health in pomerania. Int J Epidemiol 2011, 40:294-307.
• [12]Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470.
• [13]Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
• [14]Friedrich N, Alte D, Volzke H, Spilcke-Liss E, Ludemann J, Lerch MM, Kohlmann T, Nauck M, Wallaschofski H: Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Growth Horm IGF Res 2008, 18:228-237.
• [15]Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppala M: Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996, 98:2612-2615.
• [16]Iglesias P, Diez JJ, Fernandez-Reyes MJ, Mendez J, Bajo MA, Aguilera A, Selgas R: Growth hormone, IGF-I and its binding proteins (IGFBP-1 and −3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clin Endocrinol (Oxf) 2004, 60:741-749.
• [17]Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, et al.: Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int 2000, 57:423-436.
• [18]Mahesh S, Kaskel F: Growth hormone axis in chronic kidney disease. Pediatr Nephrol 2008, 23:41-48.
• [19]Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995, 95:39-45.
• [20]Handelsman DJ: Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation. Endocr Rev 1985, 6:151-182.
• [21]Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006, 17:2034-2047.
• [22]Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081.
• [23]Friedrich N, Haring R, Nauck M, Ludemann J, Rosskopf D, Spilcke-Liss E, Felix SB, Dorr M, Brabant G, Volzke H, Wallaschofski H: Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab 2009, 94:1732-1739.
• [24]Burgers AM, Biermasz NR, Schoones JW, Pereira AM, Renehan AG, Zwahlen M, Egger M, Dekkers OM: Meta-analysis and dose–response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab 2011, 96(9):2912-2920.
• [25]Blum WF, Breier BH: Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994, 4(Suppl 1):11-19.